![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 11, 2022 7:45:27 AM
Since they made the presentation available from a link on their website simultaneously with the actual presentation they do not need to release a PR to meet reporting requirements. My guess is they will hold the PR until after hours or the morning of the publication release.
The real qustion is given the results we saw yesterday why not release the data 16-17 months ago, or at least at SNO last year given the fact that they had the data in hand shortly after locking the database on October 5, 2020?
Well, we know that it hit on the two big one the primary OS outcome in ndGBM and secondary rGBM. We also know that they were willing to present the data before publishing it. LL presenting at SNO would have been as credible as at NYAS with the most targeted provider audience for your product and more press than NYAS produced. Hee are a few ideas:
- NYAS was in the big boys back yard, both pharma and Wallstreet
- LP and LG had said they would have several rapid fire press releases in a short window of time to counter the expect sell attack that we saw yesterday
- Annals of Oncology publishes their June edition tomorrow which os 10 days delayed and thus conveniently right after NYAS.
- May is Brain Cancer awareness month
- we would be foolish to believe the publication can counter the attack that was initiated by the presentation so there must be more to the plan than that.
- I have previously reported my logic for why I think approvals are pending. Now, we know that the missed PFS endpoint that was expected by most likely prevented a priori analysis of the other endpoints, but that does not mean they were not performed, can’t be published, or weren’t considered by the regulators.
- I believe the ‘mixed’ result would lead them to want to ensure approval before releasing the new SAP analysis for fear of many things. If they were looking for just appeasing shareholders and Wallstreet, why wait so darn long?
- They need cash, but yesterday’s action doesn’t make the pricing of an offer very favorable. Given how shrewd LP has been regarding capital creation, I think it is obvious that she has another plan and multiple alternatives.
My conclusion, the June 4th ASCO presentation will discuss bigger news that the great data that we saw yesterday. Either buy-out/partnership, approvals. or both.
Pins and needles folks, pins and needles
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM